The Texas Heart Institute in the US has successfully implanted BiVACOR’s total artificial heart (BTAH) in a human patient for the first time. The procedure was performed on a 57-year-old man with end-stage heart failure on July 9 as part of an FDA-approved early feasibility study (EFS) (NCT06174103). This milestone surgery is part of a…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest